Literature DB >> 23590593

Should alternatives to conventional hospitalisation be promoted in an era of financial constraint?

Juan M Pericás1, Jesús Aibar, Néstor Soler, Alfonso López-Soto, Carmen Sanclemente-Ansó, Xavier Bosch.   

Abstract

BACKGROUND: Because the current economic crisis has led to austerity in health policies, with severe restrictions on public health care, avoiding unnecessary admissions and shortening hospital stays is rapidly becoming an urgent priority. Alternatives to hospitalisation replace or shorten hospital processes, including diagnosis, monitoring, treatment and follow-up. This review aims to present the available evidence on alternatives to conventional hospitalisation for medical disorders; options for surgery, psychiatry and palliative care are largely excluded.
MATERIALS AND METHODS: Narrative review.
RESULTS: The main alternatives to conventional hospitalisation include day centres (DC), quick diagnosis units (QDU), hospital at home (HaH) and, in some circumstances, telemonitoring. DC increase patient comfort, reduce costs and can improve efficiency. In generally healthy patients with suspected severe disease, QDU may be a good alternative to hospitalisation for diagnostic procedures. However, their cost-effectiveness remains to be clearly proven. Randomised controlled trials have shown that hospital-at-home (HaH) can lead to earlier hospital discharges, improve outcomes and reduce costs in patients with prevalent chronic diseases. Although telemonitoring seems to be promising and its use is increasing, methodologically sounder studies with a higher level of evidence are needed to assess its clinical effectiveness.
CONCLUSIONS: Factors such as ageing, the need for an earlier diagnosis of suspected severe disease, the increasing complexity of medical care and the increasing costs of hospitalisation mean that, whenever possible, giving priority to less expensive alternatives to hospital admission, such as QDU, DC, HaH and telemedicine, is an urgent task in the current economic crisis.
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23590593     DOI: 10.1111/eci.12087

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia.

Authors:  Manuel Quintana-Díaz; Raúl Muñoz-Romo; Susana Gómez-Ramírez; José Pavía; Alberto M Borobia; José A García-Erce; Manuel Muñoz
Journal:  Blood Transfus       Date:  2017-01-24       Impact factor: 3.443

2.  Perception of quality of care of patients with potentially severe diseases evaluated at a distinct quick diagnostic delivery model: a cross-sectional study.

Authors:  Carmen Sanclemente-Ansó; Albert Salazar; Xavier Bosch; Cristina Capdevila; Amparo Giménez-Requena; Beatriz Rosón-Hernández; Xavier Corbella
Journal:  BMC Health Serv Res       Date:  2015-09-30       Impact factor: 2.655

3.  Sustainable medical research by effective and comprehensive medical skills: overcoming the frontiers by predictive, preventive and personalized medicine.

Authors:  Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-08-27       Impact factor: 6.543

4.  Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients.

Authors:  Xavier Bosch; Emmanuel Coloma; Carolina Donate; Lluís Colomo; Pamela Doti; Anna Jordán; Alfonso López-Soto
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

5.  Unintentional weight loss: Clinical characteristics and outcomes in a prospective cohort of 2677 patients.

Authors:  Xavier Bosch; Esther Monclús; Ona Escoda; Mar Guerra-García; Pedro Moreno; Neus Guasch; Alfons López-Soto
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

6.  Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain.

Authors:  Xavier Bosch; Carmen Sanclemente-Ansó; Ona Escoda; Esther Monclús; Jonathan Franco-Vanegas; Pedro Moreno; Mar Guerra-García; Neus Guasch; Alfons López-Soto
Journal:  BMC Cancer       Date:  2018-03-12       Impact factor: 4.430

7.  A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy.

Authors:  David Nicolás; Anna Camós-Carreras; Felipe Spencer; Andrea Arenas; Eugenia Butori; Pol Maymó; Gerard Anmella; Orla Torrallardona-Murphy; Eduarda Alves; Laura García; Irene Pereta; Eva Castells; Nuria Seijas; Begoña Ibáñez; Carme Grané; Marta Bodro; Celia Cardozo; Sonia Barroso; Victoria Olive; Marta Tortajada; Carme Hernández; David Cucchiari; Emmanuel Coloma; Juan M Pericàs
Journal:  Open Forum Infect Dis       Date:  2020-12-08       Impact factor: 3.835

8.  Primary care referrals of patients with potentially serious diseases to the emergency department or a quick diagnosis unit: a cross-sectional retrospective study.

Authors:  Xavier Bosch; Ona Escoda; David Nicolás; Emmanuel Coloma; Sara Fernández; Antonio Coca; Alfonso López-Soto
Journal:  BMC Fam Pract       Date:  2014-04-28       Impact factor: 2.497

9.  Quick outpatient diagnosis in small district or general tertiary hospitals: A comparative observational study.

Authors:  Elisabet Montori-Palacín; Sergio Prieto-González; Ignasi Carrasco-Miserachs; Jordi Altes-Capella; Yaroslau Compta; Alfons López-Soto; Xavier Bosch
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

10.  Quick diagnosis units: predictors of time to diagnosis and costs.

Authors:  Elisabet Montori-Palacín; Jordi Ramon; Yaroslau Compta; Monica Insa; Sergio Prieto-González; Ignasi Carrasco-Miserachs; Rafel X Vidal-Serra; Jordi Altes-Capella; Alfons López-Soto; Xavier Bosch
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.